Skip to main content
. 2016 Jun 30;7(35):57351–57366. doi: 10.18632/oncotarget.10344

Table 1. Expression of SERPINE1, uPA and uPAR as prognostic factors in head and neck cancer studies.

Study uPA/uPAR/SERPINE1 Protein/RNA Tumor vs Normal Prognostic significance Type N
Pavon et al 2015 [62] SERPINE1 Protein/RNA Over-expressed Poor prognosis Re-/prospective 80 & 190
Pasini et al 2001 [117] uPA/ SERPINE1 RNA Over-expressed ------ Prospective 91
Speleman et al 2007 [118] uPA/SERPINE1 Protein Over-expressed Poor prog. (SERPINE1) Prospective 46
Yasuda et al 1997 [127] uPA/SERPINE1 Protein ----- ----- NA 28
Lindberg et al 2006 [116] uPAR/SERPINE1 Protein Over-expressed ----- Retrospective 20
Nozaki et al 1998 [27] uPA/uPAR/SERPINE1 Protein ----- ------ NA 34
Strojan et al 1998 [124] uPA/SERPINE1 Protein Over-expressed ----- Prospective 58
Chin et al 2005 [128] uPA/SERPINE1 Protein Over-expressed Poor prognosis NA 62
Huang et al 2014 [84] SERPINE1 Protein Over-expressed NS Retrospective 43
Magnussen et al 2014[130] uPAR/SERPINE1 Protein Over-expressed Poor prognosis Retrospective 115
Dhanda et al 2014 [61] SERPINE1 Protein Over-expressed Poor prognosis Prospective 112
Hundsdorfer et al 2005 [131] uPA/SERPINE1 Protein Over-expressed Poor prognosis Prospective 79
Strojan et al 2000 [141] uPA/SERPINE1 Protein --- Poor prognosis (uPA) NA 47
Yoshizawa et al 2011 [140] uPA/uPAR Protein ---- Poor prognosis Retrospective 54

N:number of patients included in each study ; NS:non-significant; NA.: not available